Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensitivity to oxazolone.
Kobayashi M, Nunomura S, Gon Y, Endo D, Kishiro S, Fukunaga M, Kitahata Y, Terui T, Ra C. J Invest Dermatol. 2010 Mar; 130(3):725-31. Epub 2009 Sep 10.